CRCRX
Price
$9.90
Change
+$0.05 (+0.51%)
Updated
Apr 2 closing price
Net Assets
243.65M
VRTPX
Price
$21.91
Change
+$0.12 (+0.55%)
Updated
Apr 2 closing price
Net Assets
9.79B
Ad is loading...

CRCRX vs VRTPX

Header iconCRCRX vs VRTPX Comparison
Open Charts CRCRX vs VRTPXBanner chart's image
NYLI CBRE Real Estate
Price$9.90
Change+$0.05 (+0.51%)
VolumeN/A
Net Assets243.65M
Vanguard Real Estate II Index
Price$21.91
Change+$0.12 (+0.55%)
VolumeN/A
Net Assets9.79B
CRCRX vs VRTPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRCRX vs. VRTPX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRCRX is a Hold and VRTPX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VRTPX has more cash in the bank: 9.79B vs. CRCRX (244M). VRTPX pays higher dividends than CRCRX: VRTPX (3.92) vs CRCRX (1.26). CRCRX was incepted earlier than VRTPX: CRCRX (22 years) vs VRTPX (8 years). CRCRX (2.09) is less costly to investors than VRTPX (0.08). CRCRX is a more actively managed with annual turnover of: 78.00 vs. VRTPX (6.00). CRCRX has a lower initial minimum investment than VRTPX: CRCRX (1000) vs VRTPX (100000000). VRTPX annual gain was more profitable for investors over the last year : 13.11 vs. CRCRX (7.33). VRTPX return over 5 years is better than : 70.10 vs. CRCRX (29.61).
CRCRXVRTPXCRCRX / VRTPX
Total Expense Ratio1.930.082,413%
Annual Report Gross Expense Ratio2.090.082,612%
Fund Existence22 years8 years-
Gain YTD1.8513.28756%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets244M9.79B2%
Annual Yield % from dividends1.263.9232%
Returns for 1 year7.3313.1156%
Returns for 3 years-33.67-7.07476%
Returns for 5 years29.6170.1042%
Returns for 10 years-45.36N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNTX0.680.13
+23.57%
Context Therapeutics
OLN24.700.91
+3.83%
Olin Corp
LFMD5.610.18
+3.31%
LifeMD
HSBC57.970.71
+1.24%
HSBC Holdings PLC
ARCO8.240.01
+0.12%
Arcos Dorados Holdings